133413-91-9

Upstream product

• 114171-57-2 ethyl 2-chloro-5-fluoro-6-(p-tolylthio)nicotinate 

Downstream Products

• 921212-06-8 2-amino-5-fluoro-6-(4-methylphenylsulfonyl)-nicotinic acid methyl ester 
• 921212-08-0 2-amino-5-fluoro-6-(4-methylphenylthio)-nicotinic acid methyl ester 
• 133429-82-0 2-chloro-5-fluoro-6-(p-tolylthio)nicotinoyl chloride 
• 133414-03-6 ethyl 2-hydrazono-2-<2-chloro-5-fluoro-6-(p-tolylthio)nicotinoyl>acetate 
• 133414-09-2 ethyl 4-chloro-6-fluoro-7-(p-tolylthio)pyrido<2,3-c>pyridazine-3-carboxylate 
• 133414-08-1 ethyl 6-fluoro-4(1H)-oxo-7-(p-tolylthio)pyrido<2,3-c>pyridazine-3-carboxylate 
• 133414-00-3 <<1-ethoxycarbonyl-1-(2-chloro-5-fluoro-6-(p-tolylthio)nicotinoyl)methylene>hydrazono>triphenylphosphorane 
• 133413-97-5 ethyl 2-diazo-2-<2-chloro-5-fluoro-6-(p-tolylthio)nicotinoyl>acetate 

Relevant academic research and scientific papers

N-BENZYL-MORPHOLINE DERIVATIVES AS MODULATORS OF THE CHEMOKINE RECEPTOR

The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.

PIPERIDINE DERIVATIVES, THEIR PROCESS FOR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

The present invention provides a compound of a formula (I): [Chemical formula should be inserted here. Please see paper copy] wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the tr

PIPERIDINE DERIVATIVES, THEIR PROCESS FOR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM .

The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.